Aurinia Pharmaceuticals Inc

Q3 2025 13F Holders

Symbol
AUPH
CUSIP
05156V102
Type
Equity
Class
COM
Num filings
257
Total reported value, excl. options
$736 M
Manager Report Date Value ($000) Shares Option Type